Regnum (RGMP) Price & Analysis

3 Followers

RGMP Stock Chart & Stats

$0.01

>-$0.01(-99.00%)

At close: Jul 12 4:00 PM EDT

$0.01

>-$0.01(-99.00%)

Day’s Range― - ―

52-Week Range$0.01 - $0.01

Previous CloseN/A

Volume3.00K

Average Volume (3M)0.00

Market Cap

$23.00

Enterprise Value$774.90K

Total Cash (Recent Filing)$462.37K

Total Debt (Recent Filing)$1.57M

Price to Earnings (P/E)―

BetaN/A

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.04

Shares Outstanding22,950,000

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio-0.02

Price to Book (P/B)-2.67

Price to Sales (P/S)0.00

P/FCF Ratio-4.39

Enterprise Value/Market Cap33.69K

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-6.21

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

RGMP FAQ

What was Regnum Corp.’s price range in the past 12 months?

Regnum Corp. lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.

What is Regnum Corp.’s market cap?

Regnum Corp.’s market cap is $23.00.

When is Regnum Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Regnum Corp.’s earnings last quarter?

Currently, no data Available

Is Regnum Corp. overvalued?

According to Wall Street analysts Regnum Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Regnum Corp. pay dividends?

Regnum Corp. does not currently pay dividends.

What is Regnum Corp.’s EPS estimate?

Regnum Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Regnum Corp. have?

Regnum Corp. has 22,950,000 shares outstanding.

What happened to Regnum Corp.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Regnum Corp.?

Currently, no hedge funds are holding shares in RGMP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Regnum Corp.

Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functioning as a C-C chemokine receptor type 5 (CCR5) antagonist. This drug is specifically formulated to inhibit the human immunodeficiency virus (HIV) from gaining entry into human cells. Headquartered in New York, New York, Regnum Corp. operates as a subsidiary of Phoenixus AG.